INVIVO CAPITAL PARTNERS
Invivo is focused on investing in early-stage companies in Healthcare sector: biotech, medical devices and e-Health.
INVIVO CAPITAL PARTNERS
Social Links:
Status:
Active
Email Addresses:
[email protected]
Total Funding:
1000 K EUR
Technology used in webpage:
Apache Sectigo SSL Sectigo Organization SSL Register.IT
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
MRL Ventures Fund
MRL Ventures is Merck’s independent early-stage therapeutics venture capital fund.
Current Employees Featured
Founder
Investors List
Barcelona Ventures
Barcelona Ventures investment in Angel Round - Invivo Capital Partners
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-12-09 | Corteria Pharmaceuticals | Invivo Capital Partners investment in Seed Round - Corteria Pharmaceuticals | 12 M EUR |
| 2021-12-02 | Integra Therapeutics | Invivo Capital Partners investment in Seed Round - Integra Therapeutics | 4.5 M EUR |
| 2021-05-25 | Telomere Therapeutics | Invivo Capital Partners investment in Venture Round - Telomere Therapeutics | 1.89 M EUR |
| 2021-03-18 | MiiMOSA | Invivo Capital Partners investment in Venture Round - MiiMOSA | 7.5 M EUR |
| 2020-12-01 | Telomere Therapeutics | Invivo Capital Partners investment in Seed Round - Telomere Therapeutics | 1.5 M EUR |
| 2020-07-27 | OneChain Immunotherapeutics | Invivo Capital Partners investment in Seed Round - OneChain Immunotherapeutics | 3.05 M EUR |
| 2020-07-24 | ARTHEx Biotech | Invivo Capital Partners investment in Seed Round - ARTHEx Biotech | 4.25 M EUR |
| 2020-07-13 | Telum Therapeutics | Invivo Capital Partners investment in Seed Round - Telum Therapeutics | 4.1 M EUR |
| 2020-05-26 | Gyala Therapeutics | Invivo Capital Partners investment in Seed Round - Gyala Therapeutics | 1.5 M EUR |
| 2020-04-14 | Pulmobiotics | Invivo Capital Partners investment in Seed Round - Pulmobiotics | 2 M EUR |